Companies & Industry »Company News»Company News Details
Company News Details

BSE   16 Oct 17 | 10:07 AM

503.60 2.2 (0.44%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: 532321
Face Value: N.A.

NSE   16 Oct 17 | 10:04 AM

504.10 2.15 (0.43%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: CADILAHC
Performance
1 Week : Rs 493.50 (2.05%)
1 Month : Rs 481.20 (4.66%)
1 Year : Rs 389.00 (29.46%)
change companytradenow
Back

Cadila's stock rising: Credit Suisse

Reuters / 18 Jul 12 | 11:50 AM

Credit Suisse initiates coverage on Cadila Healthcare with an "outperform" rating and a target price of Rs 970.

Investment bank says the midcap drug maker has demonstrated "strong execution" in the United States, with a portfolio mix focusing on low competition products such as nasal sprays and injectable drugs.

Widgets Magazine

USFDA approval of its facilities in Moraiya, part of Gujarat, will re-start new approvals of its drugs in the US market, Credit Suisse adds.

"Cadila is moving up the value-chain with the launch of difficult-to formulate products and its strong execution record provides multi-year growth visibility."

Widgets Magazine

Sensex

Company Price Gain (%)
Tata Motors431.951.77
Cipla601.701.62
M & M1,345.351.43
Hind. Unilever1,261.651.21
Asian Paints1,183.951.03

Online Portfolio

You can create Online Portfolio here using the below button.

Widgets Magazine